Stratified Reproduction
By Gina Maranto, Biopolitical Times guest contributor
| 08. 03. 2011
In a slim new volume, Outsourcing the Womb: Race, Class, and Gestational Surrogacy in a Global Market (Routledge, 2011), France Winddance Twine provides multiple accounts of the ways in which racism, classism, and colorism permeate the international market for wombs and gametes. For example, Twine cites the story of a Japanese woman who backs out of a surrogacy arrangement when she learns that the gestational mother, whom she had selected on the basis of her profile and skin color, is Korean. And there is the case of the black woman seeking IVF services who is "policed" in her choices by white doctors who insist it would be "inappropriate" for her to use "white" sperm if "black" sperm were available in the bank. Or the admission of the white, would-be surrogate who tells a researcher that she would carry "a Japanese baby or a Chinese baby because they are white to me," but says that "to give birth to a Black child would add one more controversial aspect to my life and I'm not ready to be on the front...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...